ORD_22456/2025

FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Procedural & sub-applicationsDefault JudgmentsMilan CDDecision By Default—

Overview Decisions Citations Documents Timeline

Parties

Claimants

Insulet Corporation

Reps: Frank Peterreins (Peterreins Schley Patent- und Rechtsanwälte PartGmbH)

Respondents

EOFLOW Co., Ltd.

Reps: Christopher Pierce (Hoyng Rokh Monegier)

Judges

Andrea PostiglionePresiding Judge / Judge-Rapporteur
Anna-Lena KleinLegally Qualified Judge
Uwe SchwengelbeckTechnically Qualified Judge

Patents

EP 4 201 327

CPC codes: A61M5/1723, A61M5/1452, A61M5/158, A61B5/14865, A61M5/14244, F04B9/02, A61B5/14532, A61M2230/201, A61M2005/14506, A61M5/14248, B65D83/761, A61M5/3291…

Sector: Packaging & Conveying

Outcome

Infringed

Filed: —

First decided: May 28, 2025

Language: —

Decision by Milan Central Division (UPC_CFI_597/2024, 22 July 2025) on EOFLOW's revocation action and Insulet's counterclaim for infringement of EP 4 201 327 (wearable insulin pump / patch pump). The court rejected EOFLOW's revocation action (patent upheld as valid) and found EOFLOW's EOPatch product infringed the patent. The court ordered an injunction across 16 UPC member states, product recall, removal from distribution channels, destruction, and full information obligations. The decision also addressed the decision-by-default procedure, patent lexicon interpretation, and the cap on recoverable costs in parallel proceedings.

Claims

At issueall

Maintainedall

Infringedall

Notes: Milan Central Division (same decision as CC_65201/2024) found EOFLOW infringed EP 4 201 327; revocation action dismissed; patent maintained; no specific claim numbers enumerated in excerpt.